$8.39
-0.0100-0.12%
At Close: -
$8.39
00.00%
After Hours: 1:00 PM EDT
15 minutes delayed
Zymeworks
ZYMENASDAQ
Zymeworks (NASDAQ:ZYME) Stock, Analyst Ratings, Price Targets, Predictions
Zymeworks Inc has a consensus price target of $19.43, established from looking at the 40 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Citigroup on June 6, 2024, May 7, 2024, and May 3, 2024. With an average price target of $12 between HC Wainwright & Co., HC Wainwright & Co., and Citigroup, there's an implied 43.03% upside for Zymeworks Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Citigroup
Wells Fargo
Stifel
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Zymeworks
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/06/2024 | Buy Now | 19.19% | HC Wainwright & Co. | Robert Burns | $10 → $10 | Reiterates | Neutral → Neutral | Get Alert |
| 05/07/2024 | Buy Now | 19.19% | HC Wainwright & Co. | Robert Burns | → $10 | Reiterates | Neutral → Neutral | Get Alert |
| 05/03/2024 | Buy Now | 90.7% | Citigroup | Yigal Nochomovitz | $17 → $16 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 43.03% | Wells Fargo | Derek Archila | $14 → $12 | Maintains | Overweight | Get Alert |
| 03/12/2024 | Buy Now | 66.87% | Wells Fargo | Derek Archila | $12 → $14 | Maintains | Overweight | Get Alert |
| 03/11/2024 | Buy Now | 19.19% | HC Wainwright & Co. | Robert Burns | $8 → $10 | Maintains | Neutral | Get Alert |
| 08/15/2023 | Buy Now | -4.65% | HC Wainwright & Co. | Robert Burns | → $8 | Reiterates | Neutral → Neutral | Get Alert |
| 06/06/2023 | Buy Now | -4.65% | HC Wainwright & Co. | Robert Burns | → $8 | Reiterates | Neutral → Neutral | Get Alert |
| 05/18/2023 | Buy Now | 114.54% | Citigroup | Yigal Nochomovitz | $17 → $18 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | 126.46% | Stifel | Stephen Willey | $18 → $19 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 7.27% | JP Morgan | Brian Cheng | $8 → $9 | Maintains | Neutral | Get Alert |
| 03/21/2023 | Buy Now | 43.03% | Wells Fargo | Derek Archila | → $12 | Assumes | → Overweight | Get Alert |
| 03/21/2023 | Buy Now | -4.65% | HC Wainwright & Co. | Robert Burns | → $8 | Reiterates | → Neutral | Get Alert |
| 03/10/2023 | Buy Now | 102.62% | Citigroup | Yigal Nochomovitz | $21 → $17 | Maintains | Buy | Get Alert |
| 03/08/2023 | Buy Now | 90.7% | Guggenheim | Charles Zhou | → $16 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | Buy Now | -4.65% | HC Wainwright & Co. | Robert Burns | → $8 | Reiterates | → Neutral | Get Alert |
| 01/20/2023 | Buy Now | 19.19% | SVB Leerink | Andrew Berens | $8 → $10 | Maintains | Market Perform | Get Alert |
| 01/04/2023 | Buy Now | -4.65% | HC Wainwright & Co. | Robert Burns | $10 → $8 | Maintains | Neutral | Get Alert |
| 12/22/2022 | Buy Now | 7.27% | Barclays | Gena Wang | $7 → $9 | Maintains | Equal-Weight | Get Alert |
| 12/20/2022 | Buy Now | 31.11% | Jefferies | Akash Tewari | $7.7 → $11 | Upgrade | Hold → Buy | Get Alert |
| 11/21/2022 | Buy Now | 19.19% | HC Wainwright & Co. | Robert Burns | $8 → $10 | Maintains | Neutral | Get Alert |
| 11/01/2022 | Buy Now | -4.65% | HC Wainwright & Co. | Robert Burns | $40 → $8 | Downgrade | Buy → Neutral | Get Alert |
| 10/24/2022 | Buy Now | 114.54% | Stifel | Stephen Willey | $21 → $18 | Maintains | Buy | Get Alert |
| 10/21/2022 | Buy Now | -4.65% | SVB Leerink | Andrew Berens | $19 → $8 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/04/2022 | Buy Now | 7.27% | Wells Fargo | Nick Abbott | $45 → $9 | Assumes | → Overweight | Get Alert |
| 09/14/2022 | Buy Now | 150.3% | Citigroup | Yigal Nochomovitz | $27 → $21 | Maintains | Buy | Get Alert |
| 08/26/2022 | Buy Now | 221.81% | Citigroup | Yigal Nochomovitz | $28 → $27 | Maintains | Buy | Get Alert |
| 05/27/2022 | Buy Now | 126.46% | SVB Leerink | Andrew Berens | $18 → $19 | Maintains | Outperform | Get Alert |
| 05/23/2022 | Buy Now | 376.76% | HC Wainwright & Co. | Robert Burns | $44 → $40 | Maintains | Buy | Get Alert |
| 05/09/2022 | Buy Now | 233.73% | Citigroup | Yigal Nochomovitz | $30 → $28 | Maintains | Buy | Get Alert |
| 05/09/2022 | Buy Now | 233.73% | Citigroup | Yigal Nochomovitz | $30 → $28 | Maintains | Buy | Get Alert |
| 05/05/2022 | Buy Now | 66.87% | Guggenheim | Charles Zhu | → $14 | Upgrade | Neutral → Buy | Get Alert |
| 03/15/2022 | Buy Now | 78.78% | Evercore ISI Group | Josh Schimmer | → $15 | Initiates | → Outperform | Get Alert |
| 02/28/2022 | Buy Now | 257.57% | Citigroup | Yigal Nochomovitz | $53 → $30 | Maintains | Buy | Get Alert |
| 02/09/2022 | Buy Now | 472.11% | Wells Fargo | Jim Birchenough | $56 → $48 | Maintains | Overweight | Get Alert |
| 12/10/2021 | Buy Now | 782% | Raymond James | David Novak | — | Downgrade | Strong Buy → Outperform | Get Alert |
| 12/10/2021 | Buy Now | — | SVB Leerink | Andrew Berens | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/10/2021 | Buy Now | 221.81% | SVB Leerink | Andrew Berens | — | Maintains | Market Perform | Get Alert |
| 11/04/2021 | Buy Now | 233.73% | SVB Leerink | Andrew Berens | — | Maintains | Market Perform | Get Alert |
| 08/05/2021 | Buy Now | 424.43% | HC Wainwright & Co. | Robert Burns | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Zymeworks (ZYME) stock?
The latest price target for Zymeworks (NASDAQ:ZYME) was reported by HC Wainwright & Co. on June 6, 2024. The analyst firm set a price target for $10.00 expecting ZYME to rise to within 12 months (a possible 19.19% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zymeworks (ZYME)?
The latest analyst rating for Zymeworks (NASDAQ:ZYME) was provided by HC Wainwright & Co., and Zymeworks reiterated their neutral rating.
When was the last upgrade for Zymeworks (ZYME)?
The last upgrade for Zymeworks Inc happened on December 20, 2022 when Jefferies raised their price target to $11. Jefferies previously had a hold for Zymeworks Inc.
When was the last downgrade for Zymeworks (ZYME)?
The last downgrade for Zymeworks Inc happened on November 1, 2022 when HC Wainwright & Co. changed their price target from $40 to $8 for Zymeworks Inc.
When is the next analyst rating going to be posted or updated for Zymeworks (ZYME)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zymeworks, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zymeworks was filed on June 6, 2024 so you should expect the next rating to be made available sometime around June 6, 2025.
Is the Analyst Rating Zymeworks (ZYME) correct?
While ratings are subjective and will change, the latest Zymeworks (ZYME) rating was a reiterated with a price target of $10.00 to $10.00. The current price Zymeworks (ZYME) is trading at is $8.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.